Daver, N., Sochacki, A., Malki, M. M. A., Wang, E., Muller, M., Bellon, A., Micallef, S., Sallman, D., Larkin, K. (2025). A phase 1/2, first-in-human, multicenter, open-label trial evaluating the safety, tolerability, and antileukemic activity of Debio 1562M in patients with recurrent refractory acute myeloid leukemia (AML). Blood. https://doi.org/10.1182/blood-2025-5194